Ovarian Cancer Market

Table of Content

1. Introduction
   • Definition of Ovarian Cancer Market
   • Scope of the Report
2. Methodology
   • Executive Summary
   • Market Overview
   • Market Definition and Segmentation
3. Market Dynamics
   • Drivers
   • Restraints
   • Opportunities
   • Porter's Five Forces Analysis
   • PESTEL Analysis
4. Ovarian Cancer Market, By Treatment Type
   • Chemotherapy
   • Targeted Therapy
   • Others
5. Ovarian Cancer Market, By Route of Administration
   • Oral
   • Parenteral
   • Others
6. Ovarian Cancer Market, By Distribution Channel
   • Hospital Pharmacy
   • Online Pharmacy
   • Retail Pharmacy
7. Ovarian Cancer Market, By End-Users
   • Hospitals
   • Homecare
   • Speciality Centres
   • Others
8. Ovarian Cancer Market, By Geography
   • North America
     • United States
     • Canada
   • Europe
     • United Kingdom
     • Germany
     • France
     • Spain
     • Italy
     • Rest of Europe
   • Asia-Pacific
     • China
     • Japan
     • India
     • South Korea
     • Australia
     • Rest of Asia-Pacific
   • Latin America
     • Brazil
     • Mexico
     • Rest of Latin America
   • Middle East & Africa
     • Saudi Arabia
     • United Arab Emirates
     • South Africa
     • Rest of Middle East & Africa
9. Competitive Landscape
10. Company Profiles
    • Mylan N.V. (U.S.)
      • Company Overview
      • Product Portfolio and Description
      • Key Highlights
      • Financial Overview
    • Teva Pharmaceutical Industries Ltd.(Ireland)
    • Sanofi (France)
    • Pfizer Inc. (U.S.)
    • GlaxoSmithKline plc (U.K.)
    • Novartis AG (Switzerland)
    • Bayer AG (Germany)
    • Eli Lilly and Company (U.S.)
    • Merck & Co., Inc. (U.S.)
    • Allergan (Ireland)
    • AstraZeneca (U.K.)
    • Johnson & Johnson Private Limited (U.S.)
    • Cipla Inc. (U.S.)
    • Abbott (U.S.)
    • AbbVie Inc. (U.S.)
    • Merck KGaA (Germany)
    • LEO Pharma A/S (Denmark)
    • Bausch Health Companies Inc. (Canada)
    • Sun Pharmaceutical Industries Ltd. (India)
    • Aurobindo Pharma (India)
    • Lupin (India)
    • Hikma Pharmaceuticals PLC (U.K.)
    • Amneal Pharmaceuticals LLC. (U.S.)
11. Conclusion and Future Outlook
12. Appendix
    • Research Methodology
    • About the Pharmanucleus
13. Disclaimer